Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Prospects
|
August 25, 2020
After this, nothing happened
Alan Block
The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons
|
March 16, 2005
Evaluation of ultrasound-guided extracorporeal shock wave therapy (ESWT) in the treatment of chronic plantar fasciitis
Christopher F Hyer, Robert Vancourt, Alan Block
The American Journal of Cardiology
|
September 5, 2002
Comparison of the effects of omapatrilat and lisinopril on circulating neurohormones and cytokines in patients with chronic heart failure
Tej Sheth, Tom Parker, Alan Block, et al.
Transplantation
|
March 5, 2011
Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT and BENEFIT-EXT studies)
Yves Vanrenterghem, Barbara Bresnahan, Josep Campistol, et al.
Transplantation
|
November 16, 2010
Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies
Christian P Larsen, Josep Grinyó, José Medina-Pestana, et al.
Arthritis Care & Research
|
July 3, 2010
Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritis
Nicolino Ruperto, Daniel J Lovell, Tracy Li, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Prospects
|
August 25, 2020
After this, nothing happened
Alan Block
The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons
|
March 16, 2005
Evaluation of ultrasound-guided extracorporeal shock wave therapy (ESWT) in the treatment of chronic plantar fasciitis
Christopher F Hyer, Robert Vancourt, Alan Block
The American Journal of Cardiology
|
September 5, 2002
Comparison of the effects of omapatrilat and lisinopril on circulating neurohormones and cytokines in patients with chronic heart failure
Tej Sheth, Tom Parker, Alan Block, et al.
Transplantation
|
March 5, 2011
Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT and BENEFIT-EXT studies)
Yves Vanrenterghem, Barbara Bresnahan, Josep Campistol, et al.
Transplantation
|
November 16, 2010
Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies
Christian P Larsen, Josep Grinyó, José Medina-Pestana, et al.
Arthritis Care & Research
|
July 3, 2010
Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritis
Nicolino Ruperto, Daniel J Lovell, Tracy Li, et al.
Page
of 1